A Canadian securities executive believes psychedelics investment opportunities at their core relate most to the pharmaceutical industry.
The Investing News Network met online with Richard Carleton, CEO of the Canadian Securities Exchange (CSE), to discuss the growth potential of psychedelics as an investment and the role he expects his exchange to see.
Carleton also discussed the first time he heard about the psychedelics investment proposal and what his reaction was at that time.
Investing News Network (INN)
Find out more about investing by INN @
Follow this link to learn more about Psychedelics ↓
Want a FREE investor kit? Download here↓
Follow us on Twitter: @INN_Resource